When it comes to expensive pharmaceutical treatments, there’s a new entry that’s likely to renew the debate about drug prices. Biogen’s (BIIB) new medication Spinraza, which treats a rare spinal disorder in children and adults called spinal muscular atrophy (SMA), will carry.
So rather than being reimbursed at AWP -5%, these drugs will be paid at the ASP .. January 3: The FDA approved Spinraza (nusin- ersen) to.
(AWP) annually thereafter, • Drug Information: Spinraza is the first medication approved by the FDA for the treatment of spinal.
Variable rate hi low method Administration FDA has approved SPINRAZA TM nusinersen under Priority Review download free unicorn wallpaper the treatment of spinal muscular atrophy SMA in pediatric and spinraza awp patients. Coagulation abnormalities and thrombocytopenia, including acute severe thrombocytopenia, have been observed after administration of some antisense oligonucleotides. Lynne Spinraza awpchief operating officer of Ionis.